STOCK TITAN
  1. Home
  2. Financials
  3. CRSP
  4. Revenue

CRISPR Therapeutics AG (CRSP) Revenue by Year

CRSP

CRISPR Therapeutics AG generated $3.5M in revenue in fiscal year 2025. This represents a decrease of 90.6% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $13.4M in revenue. The table below carries 12 fiscal years, from 2014 to 2025, and the quarters CRISPR Therapeutics AG has filed alongside them.

FY2025 annual
Revenue $3.5M
YoY -90.6%
5Y CAGR +37.3%
10Y CAGR +30.4%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

CRSP Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-K
Revenue$13.4M$3.5M-90.6%$37.3M-89.9%$371.2M+30885.5%$1.2M-99.9%$915.0M+127154.9%$719K-99.8%$289.6M+9169.8%$3.1M-92.4%$41.0M+693.9%$5.2M+1990.7%$247KN/A

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

CRSP Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Revenue$10.2M+1041.4%$1.5M+68.6%$864K-97.6%$889K+47.7%$892K+72.5%$865K+71.6%$35.7M$602K$517K-99.3%$504K-99.5%N/A$0-100.0%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More CRISPR Therapeutics AG financials

Frequently Asked Questions

What was CRISPR Therapeutics AG's revenue in fiscal year 2025?

CRISPR Therapeutics AG generated $3.5M in revenue in fiscal year 2025.

How fast is CRISPR Therapeutics AG's revenue growing?

CRISPR Therapeutics AG (CRSP) revenue fell by 90.6% year over year, from $37.3M to $3.5M in fiscal year 2025.

What is CRISPR Therapeutics AG's revenue over the last twelve months?

CRISPR Therapeutics AG (CRSP) reported $13.4M in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

CRISPR Therapeutics AG (CRSP) reported $10.2M in revenue in Q2 2026. This represents an increase of 1041.4% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what CRISPR Therapeutics AG (CRSP) reported on that line in every period on record.